Table 2.
Lymphocyte subsets and sPD-1 levels.
| n | WM group | EA group | t | P | ||
|---|---|---|---|---|---|---|
| CD3 + T (%) | 30 | T0 | 58.06 ± 11.14 | 60.12 ± 11.22 | 0.713 | 0.479 |
| T1 | 59.33 ± 10.42 | 60.89 ± 11.35 | 0.840 | 0.404 | ||
| T2 | 61.04 ± 10.30 | 66.84 ± 8.75∗ | 2.351 | 0.022 | ||
|
| ||||||
| CD4 + T (%) | 30 | T0 | 37.26 ± 11.10 | 37.07 ± 8.65 | -0.022 | 0.983 |
| T1 | 37.74 ± 9.49 | 38.32 ± 8.50 | 0.149 | 0.882 | ||
| T2 | 39.50 ± 10.46 | 45.47 ± 7.78∗ | 2.176 | 0.034 | ||
|
| ||||||
| NK cells (%) | 30 | T0 | 20.45 ± 9.95 | 20.13 ± 8.00 | -0.137 | 0.892 |
| T1 | 17.56 ± 7.50 | 18.29 ± 7.95 | 0.369 | 0.714 | ||
| T2 | 16.93 ± 6.93 | 21.71 ± 8.06∗ | 2.463 | 0.017 | ||
|
| ||||||
| sPD-1 (pg/mL) | 30 | T0 | 141.22 ± 41.05 | 142.77 ± 36.57 | -0.155 | 0.877 |
| T1 | 138.62 ± 38.86 | 134.23 ± 31.71 | -0.466 | 0.643 | ||
| T2 | 137.87 ± 41.90 | 116.28 ± 36.83∗ | -2.119 | 0.038 | ||
CD3 + T: percentage of CD3 + T lymphocytes; CD4 + T: percentage of CD4 + T lymphocytes; NK cells: percentage of natural killer cells; sPD-1: level of programmed death factor in plasma; T0: before treatment; T1 and T2: three and five days after treatment, respectively. Data are presented as means ± SD or as median (IQR). ∗Compared with the WM group, P < 0.05.